MX9709782A - Derivados de aciclovir para aplicacion topica. - Google Patents

Derivados de aciclovir para aplicacion topica.

Info

Publication number
MX9709782A
MX9709782A MX9709782A MX9709782A MX9709782A MX 9709782 A MX9709782 A MX 9709782A MX 9709782 A MX9709782 A MX 9709782A MX 9709782 A MX9709782 A MX 9709782A MX 9709782 A MX9709782 A MX 9709782A
Authority
MX
Mexico
Prior art keywords
acyclovir
herpes
topical use
strains
well
Prior art date
Application number
MX9709782A
Other languages
English (en)
Other versions
MXPA97009782A (es
Inventor
Karl Y Hostetler
Original Assignee
Karl Y Hostetler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Y Hostetler filed Critical Karl Y Hostetler
Publication of MX9709782A publication Critical patent/MX9709782A/es
Publication of MXPA97009782A publication Critical patent/MXPA97009782A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a composiciones para aplicacion topica utiles en infecciones causadas por el virus del herpes, que comprenden ésteres de fosfato análogos de nucleosidos contra el herpes, tales como el monofosfato de aciclovir, difosfato de aciclovir y trifosfato de aciclovir, los cuales muestran una mayor actividad contra las cepas naturales del virus del herpes así como contra cepas resistentes, particularmente cepas negativas para la enzima timidina cinasa del virus. Los ésteres de fosfato análogos de nucleosidos incluye los fosforaidatos y fosfotiaratos, así como polifosfatos que tienen puentes con átomos de C y S.
MXPA/A/1997/009782A 1995-06-07 1997-12-05 Derivados de aciclovir para aplicacion topica MXPA97009782A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/480,456 US5879700A (en) 1991-10-15 1995-06-07 Nucleoside analogue phosphates for topical use
US08480456 1995-06-07

Publications (2)

Publication Number Publication Date
MX9709782A true MX9709782A (es) 1998-10-31
MXPA97009782A MXPA97009782A (es) 1999-01-11

Family

ID=

Also Published As

Publication number Publication date
JPH11507642A (ja) 1999-07-06
CA2222154A1 (en) 1996-12-19
US5879700A (en) 1999-03-09
KR19990022471A (ko) 1999-03-25
EP0831794A1 (en) 1998-04-01
WO1996040088A1 (en) 1996-12-19
CN1192138A (zh) 1998-09-02
EP0831794A4 (en) 1998-11-04
AU6384296A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
De Clercq Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and-pyrimidines
IL98702A (en) 9-purinyl phosphonic acid derivatives their preparation and pharmaceutical compositions containing them
CA2215190A1 (en) Aryl-ester phosphoramidate derivatives of nucleosides
MY121839A (en) Antiviral purine derivatives
CA2005815A1 (en) Antiviral acyclic nucleoside derivatives
KR870006900A (ko) 항바이러스 조성물
CA2102782A1 (en) 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
ZA200108283B (en) Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs.
ATE287414T1 (de) Antitumorale uridinderivate
GR3026166T3 (en) Conformationally locked nucleoside analogues
HK1036069A1 (en) Nucleosides with anti-hepatitis b virus activity
IE831386L (en) Pharmaceutical compositions based on xylosides and lyxosides¹of purine and pyrimidine bases
MX9709782A (es) Derivados de aciclovir para aplicacion topica.
CA2355712A1 (en) Antiviral nucleoside analogues
WO2000016755A3 (en) Antiviral combinations of lamivudine and adefovir
MX9601153A (es) Metodo para inhibir el transporte de nucleosido y nucleobase en celulas de mamiferos, y metodo para inhibir la replicacion de virus.
AU5312586A (en) Composition and method for treatment of tumors with UDPG
De Clercq Antiviral activity spectrum of nucleoside and nucleotide analogues
Miura et al. 4′-Thioadenosine as a novel inhibitor of S-adenosylhomocysteine hydrolase and an inducer for the differentiation of HL-60 human leukemia cells
EP0665016A4 (en) MEANS TO RESTORE HEART FUNCTION.
ZA913482B (en) New therapeutic use of purine compounds
WO1993000099A3 (de) Verwendung von pyrimidin- und purinnucleosiden zur prophylaxe und/oder behandlung von durch adenoviren verursachten infektionen
MX9709788A (es) Analogos de nucleotidos para tratamiento topico de enfermedades proliferativas de la piel.
JPS6429394A (en) Purine nucleoside derivative
Johansson et al. 2’, 3’-Dideoxycytidine Phosphorylation by Recombinant Mouse and Human Deoxycytidine Kinase